Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target applications and new indications are driving the growth of this market. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the neuromodulation market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals act as restraints hindering its market growth.

https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

https://www.marketsandmarkets.com/pdfdownload.asp?id=921

Scope of the Report:

This research report categorizes the neuromodulation market into the following segments and sub-segments:

Neuromodulation Market, by Technology

• Internal Neuromodulation
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
• External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

Neuromodulation Market, by Application

• Spinal Cord Stimulation
  • Chronic Pain
  • Failed Back Surgery
  • Ischemia
• Deep Brain Stimulation
  • Parkinson's disease
  • Tremor
  • Depression
  • Others ( Alzheimer's disease, Dystonia, Tourette syndrome)
• Sacral Nerve Stimulation
  • Urine Incontinence
  • Fecal Incontinence
• Vagus Nerve Stimulation Market
  • Epilepsy

Others (Heart failure, Tinnitus)

• Gastric Electrical Stimulation
  • Gastroparesis
  • Obesity
• Transcranial Magnetic Stimulation
  • Depression
  • Migraine headaches
• Transcutaneous Electrical Nerve Stimulation
  • Treatment Resistant Depression
  • Others ( Stroke, Tinnitus)

Neuromodulation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe (RoE)
• Asia
  • China
  • Japan
  • India
  • Rest of Asia (RoA)
• Rest of the World (RoW)